David J Thurman1, Rosemarie Kobau2, Yao-Hua Luo3, Sandra L Helmers1, Matthew M Zack3. 1. Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA. 2. Epilepsy Program, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: rkobau@cdc.gov. 3. Epilepsy Program, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Abstract
INTRODUCTION: Community-based and other epidemiologic studies within the United States have identified substantial disparities in health care among adults with epilepsy. However, few data analyses addressing their health-care access are representative of the entire United States. This study aimed to examine national survey data about adults with epilepsy and to identify barriers to their health care. MATERIALS AND METHODS: We analyzed data from U.S. adults in the 2010 and the 2013 National Health Interview Surveys, multistage probability samples with supplemental questions on epilepsy. We defined active epilepsy as a history of physician-diagnosed epilepsy either currently under treatment or accompanied by seizures during the preceding year. We employed SAS-callable SUDAAN software to obtain weighted estimates of population proportions and rate ratios (RRs) adjusted for sex, age, and race/ethnicity. RESULTS: Compared to adults reporting no history of epilepsy, adults reporting active epilepsy were significantly more likely to be insured under Medicaid (RR=3.58) and less likely to have private health insurance (RR=0.58). Adults with active epilepsy were also less likely to be employed (RR=0.53) and much more likely to report being disabled (RR=6.14). They experience greater barriers to health-care access including an inability to afford medication (RR=2.40), mental health care (RR=3.23), eyeglasses (RR=2.36), or dental care (RR=1.98) and are more likely to report transportation as a barrier to health care (RR=5.28). CONCLUSIONS: These reported substantial disparities in, and barriers to, access to health care for adults with active epilepsy are amenable to intervention. Published by Elsevier Inc.
INTRODUCTION: Community-based and other epidemiologic studies within the United States have identified substantial disparities in health care among adults with epilepsy. However, few data analyses addressing their health-care access are representative of the entire United States. This study aimed to examine national survey data about adults with epilepsy and to identify barriers to their health care. MATERIALS AND METHODS: We analyzed data from U.S. adults in the 2010 and the 2013 National Health Interview Surveys, multistage probability samples with supplemental questions on epilepsy. We defined active epilepsy as a history of physician-diagnosed epilepsy either currently under treatment or accompanied by seizures during the preceding year. We employed SAS-callable SUDAAN software to obtain weighted estimates of population proportions and rate ratios (RRs) adjusted for sex, age, and race/ethnicity. RESULTS: Compared to adults reporting no history of epilepsy, adults reporting active epilepsy were significantly more likely to be insured under Medicaid (RR=3.58) and less likely to have private health insurance (RR=0.58). Adults with active epilepsy were also less likely to be employed (RR=0.53) and much more likely to report being disabled (RR=6.14). They experience greater barriers to health-care access including an inability to afford medication (RR=2.40), mental health care (RR=3.23), eyeglasses (RR=2.36), or dental care (RR=1.98) and are more likely to report transportation as a barrier to health care (RR=5.28). CONCLUSIONS: These reported substantial disparities in, and barriers to, access to health care for adults with active epilepsy are amenable to intervention. Published by Elsevier Inc.
Entities:
Keywords:
Access to care; Epidemiology; Epilepsy; Insurance; Surveillance; United States
Authors: Daniel R Brooks; Ruzan Avetisyan; Kelli M Jarrett; Amresh Hanchate; G D Shapiro; M J Pugh; Dan R Berlowitz; David Thurman; Georgia Montouris; Lewis E Kazis Journal: Epilepsy Behav Date: 2011-12-20 Impact factor: 2.937
Authors: Charles E Begley; Rituparna Basu; Thomas Reynolds; David R Lairson; Stephanie Dubinsky; Michael Newmark; Forbes Barnwell; Allen Hauser; Dale Hesdorffer; Nora Hernandez; Steven C Karceski; Tina Shih Journal: Epilepsia Date: 2008-11-17 Impact factor: 5.864
Authors: Jorge G Burneo; Nathalie Jette; William Theodore; Charles Begley; Karen Parko; David J Thurman; Samuel Wiebe Journal: Epilepsia Date: 2009-09-03 Impact factor: 5.864
Authors: Esma Cihan; Dale C Hesdorffer; Michael Brandsoy; Ling Li; David R Fowler; Jason K Graham; Michael Karlovich; Elizabeth J Donner; Orrin Devinsky; Daniel Friedman Journal: Neurology Date: 2020-04-23 Impact factor: 9.910
Authors: Wyatt P Bensken; Guadalupe Fernandez-Baca Vaca; Barbara C Jobst; Scott M Williams; Kurt C Stange; Martha Sajatovic; Siran M Koroukian Journal: Neurology Date: 2021-10-27 Impact factor: 11.800
Authors: Wyatt P Bensken; Suparna M Navale; Angeline S Andrew; Barbara C Jobst; Martha Sajatovic; Siran M Koroukian Journal: Med Care Date: 2021-07-01 Impact factor: 3.178
Authors: Jon Mark Dickson; Richard Jacques; Markus Reuber; Julian Hick; Mike J Campbell; Rebeka Morley; Richard A Grünewald Journal: BMJ Open Date: 2018-10-21 Impact factor: 2.692